Exosomes are 40-100 nm vesicles that are released from both normal and cancer cells into the extracellular space and can be detected in all biofluids. They are produced from multivesicular intracellular structures and are released by exocytosis, containing in their membrane both general exosomal markers of tetraspanin family (CD9, CD63, CD81), and markers of the parent cell from which they originated. Also their cargo reflects their cell of origin. Exosomes can contain mRNA, microRNAs, tumor antigens, immunomodulatory molecules, and other substances, and they are likely involved in intercellular communication. Analysis of exosomes has both scientific and diagnostic applications. Fig.1: Principle of formation and release of the exosomes. For isolation of exosomes, both physical and immunoaffinity methods are being used. Physical methods are based on separation of the vesicles according to their size and involve centrifugation, filtration, size-exclusion chromatography etc. A disadvantage is that the product can be contaminated by e.g. apoptotic vesicles or lipoproteins. The immunoaffinity methods utilize immunoprecipitating antibodies specific to antigens present in extracellular leaflet of exosomal membrane, attached to immunosorbent particles or to ELISA wells.
Antigen
Antibody clone
Catalog no.
Format
Reactivity
Application
Hu CD9
MEM-61
11-208-C100
purified
human
WB, IHC, FC
10-208-C100
purified azide free
WB, IHC, FC, FUNC
1B-208-C100
biotin
PB-208-T100
Pacific Blue™
FC
1F-208-T100
FITC
A4-208-T100
Alexa Fluor® 488
1P-208-T100
PE
1A-208-T100
APC
A6-208-T100
Alexa Fluor® 647
T4-208-T100
APC-Cy™7
Ms CD9
EM-04
11-567-C100
mouse
WB, IP, ICC, FC
1B-567-C100
1F-567-C100
1P-567-C100
1A-567-C100
Bov CD9
IVA50
11-354-C100
cow, (human)*
WB, IP, FC
A4-354-C100
WB, FC
Hu CD63
MEM-259
11-343-C100
IP, FC, ICC, IHC(P)
1B-343-C100
1F-343-T100
A4-343-T100
ICC, FC, IHC(P)
1P-343-T100
1A-343-T100
T8-343-T100
PE-Cy™5
PC-343-T100
PerCP
T9-343-T100
PerCP-Cy™5.5
Hu CD81
M38
11-558-C100
human, rabbit, cat
IP, FC, WB, ICC, IHC(P)
12-558-C100
purified low endotoxin
FUNC, IP, FC, WB, ICC, IHC(P)
1B-558-C100
PB-558-T100
1F-558-T100
A4-558-T100
FC, WB, ICC, IHC(P)
1P-558-T100
1A-558-T100
T4-558-T100
*Crossreactivity Further reading: Yu LL, Zhu J, Liu JX, Jiang F, Ni WK, Qu LS, Ni RZ, Lu CH, Xiao MB: A comparison of traditional and novel methods for the separation of exosomes from human samples. Biomed Res Int. 2018 Jul 26;2018:3634563. Wu SC, Kuo PJ, Rau CS, Wu YC, Wu CJ, Lu TH, Lin CW, Tsai CW, Hsieh CH: Subpopulations of exosomes purified via different exosomal markers carry different microRNA contents. Int J Med Sci. 2021 Jan 1;18(4):1058-1066. Mathieu M, Martin-Jaular L, Lavieu G, Théry C: Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019 Jan;21(1):9-17. Khushman M, Bhardwaj A, Patel GK, Laurini JA, Roveda K, Tan MC, Patton MC, Singh S, Taylor W, Singh AP: Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens. Pancreas 2017 Jul;46(6):782-788. Cumba Garcia LM, Peterson TE, Cepeda MA, Johnson AJ, Parney IF: Isolation and analysis of plasma-derived exosomes in patients with glioma. Front Oncol. 2019 Jul 16;9:651. Li A, Zhang T, Zheng M, Liu Y, Chen Z: Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017 Dec 27;10(1):175.
Contact: info@exbio.cz
Development of advanced analytical kits launched by EXBIO
ISLH 2024 conference is coming - we look forward to a personal meeting with you on EXBIO booth!
Good news should travel fast